Solvay Shares Decline Midday Following Dual Downgrade by Analysts

Analyst Downgrades

ING Bank reduced its price target on January 28, from 30 to 26 euros, while downgrading its recommendation from buy to hold. This adjustment reflects a revision of expectations regarding the group's ability to maintain its trajectory in a challenging sector environment. There is now a limited upside potential of 3.4% compared to the current price.

Earlier in the month, on January 8, Bernstein also revised its stance by lowering its recommendation from outperform to market perform, and reducing its price target from 29 to 27 euros. These successive reevaluations indicate increased caution among financial analysts concerning the prospects of the basic chemicals specialist, which employs about 9,000 staff and posted a revenue of 4.7 billion euros in 2024. The market consensus remains mixed on the group's ability to generate significant short-term growth.

Technical Analysis

From a technical standpoint, the stock is currently at its support level of 24.80 euros, which now becomes a critical threshold to prevent further bearish acceleration. The RSI at 39 indicates selling pressure, though it has not yet reached the oversold zone. The stock's position remains significantly below its moving averages, with a 50-day moving average at 27.03 euros and a 200-day moving average at 28.34 euros, signaling a weakening of the medium-term trend.

The immediate resistance is at 27.52 euros, posing a major hurdle for any technical rebound. The one-month volatility stands at 9.20%, reflecting significant fluctuations in an uncertain market environment. The group is set to publish its annual 2025 results on February 24, a key event that could provide clarity on the evolution of its activities and its outlook in specialty chemicals.